A Case of Advanced Lung Cancer with Cytokine Release Syndrome Caused Tremelimumab and Durvalumab Combination Therapy That Was Successfully Treated with Early Tocilizumab
A Case of Advanced Lung Cancer with Cytokine Release Syndrome Caused Tremelimumab and Durvalumab Combination Therapy That Was Successfully Treated with Early Tocilizumab
Ayaka Ohiwa, Akihiko Yagi, Hisamichi Yuda, Aiko Ebihara et al.
Citations
1 citations
Journal
Haigan
Topics
Cancer Immunotherapy and Biomarkers
Field-Weighted Citation Impact (FWCI)
1.05
article
A Case of Advanced Lung Cancer with Cytokine Release Syndrome Caused Tremelimumab and Durvalumab Combination Therapy That Was Successfully Treated with Early Tocilizumab
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
A Case of Advanced Lung Cancer with Cytokine Release Syndrome Caused Tremelimumab and Durvalumab Combination Therapy That Was Successfully Treated with Early Tocilizumab — Ayaka Ohiwa, Akihiko Yagi, et al. · Haigan (2025) | TGRS Research Map | TGRS